Category: Clinical Breakthroughs
-
Curated Cancer Care
Physicians and scientists in the Lurie Cancer Center’s OncoSET program are teaming up to help pioneer precision oncology.
-
Shorter Treatment for Hepatitis C Shown To Be Equally Effective
A new, shorter drug regimen to treat certain types of Hepatitis C was found to be as effective as the current, longer treatment, according to the findings of a large multi-center trial published in the New England Journal of Medicine.
-
Machines See the Future for Patients Diagnosed With Brain Tumors
Scientists have developed software that can forecast the survival of patients diagnosed with glioma that is more accurate than physicians’ predictions.
-
The Coffee Cannabis Connection
A new Northwestern Medicine study has discovered coffee changes many more metabolites in the blood than previously known, including those in the endocannabinoid system.
-
Exploring New Insights Into Prostate Cancer Treatment and Screening
Maha Hussain, MD, recently published several papers detailing new findings in metastatic castration-resistant prostate cancer treatment and prostate cancer screening.
-
New Findings Contradict ‘Obesity Paradox’
A new study debunks the “obesity paradox,” a counterintuitive finding that people with cardiovascular disease live longer if they are overweight or obese.
-
Female Surgical Residents Experience More Burnout Than Male Peers
A Northwestern Medicine study found women in surgical residencies work more hours and experience greater rates of burnout compared to their male peers.
-
Stretchable Electronics a ‘Game Changer’ for Stroke Recovery Treatment
A groundbreaking new wearable device developed by Northwestern scientists and designed to be worn on the throat could be a game-changer in the field of stroke rehabilitation.
-
New Microfluidic Devices Help Athletes and Enhance Physical Rehab
A new wearable microfluidic system that monitors sweat loss and analyzes sweat chemistry, developed at Northwestern, is being brought into widespread distribution.
-
Evaluating Quality of Life After Kidney Cancer Treatments
Patients with an advanced form of kidney cancer have similar quality of life outcomes on a therapy called cabozantinib, compared to those on a standard treatment.
